Qinguo Mo

860 total citations
27 papers, 606 citations indexed

About

Qinguo Mo is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Qinguo Mo has authored 27 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 9 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Qinguo Mo's work include Breast Cancer Treatment Studies (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Breast Implant and Reconstruction (5 papers). Qinguo Mo is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Breast Implant and Reconstruction (5 papers). Qinguo Mo collaborates with scholars based in China. Qinguo Mo's co-authors include Qinghong Qin, Changyuan Wei, Qixing Tan, Weiping Yang, Jian‐Hong Zhong, Liang Ma, Wen‐Feng Gong, Le‐Qun Li, Xing Liu and Bang‐De Xiang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Qinguo Mo

27 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qinguo Mo China 14 213 165 160 158 144 27 606
Miral S. Grandhi United States 8 173 0.8× 198 1.2× 163 1.0× 117 0.7× 144 1.0× 39 544
Yifu He China 16 191 0.9× 283 1.7× 92 0.6× 97 0.6× 238 1.7× 78 717
Marina Ichetovkin United States 5 124 0.6× 319 1.9× 171 1.1× 67 0.4× 202 1.4× 6 632
Norio Noguchi Japan 17 144 0.7× 203 1.2× 345 2.2× 277 1.8× 266 1.8× 41 844
Hongchuan Zhao China 14 81 0.4× 171 1.0× 146 0.9× 192 1.2× 129 0.9× 39 645
Tianyi Chi China 12 113 0.5× 181 1.1× 242 1.5× 119 0.8× 145 1.0× 29 582
Nguyen H. Tran United States 11 122 0.6× 147 0.9× 97 0.6× 111 0.7× 249 1.7× 59 470
Tsai‐Sheng Yang Taiwan 12 151 0.7× 194 1.2× 308 1.9× 116 0.7× 315 2.2× 37 733
Yu Wen China 9 98 0.5× 168 1.0× 168 1.1× 123 0.8× 175 1.2× 17 622

Countries citing papers authored by Qinguo Mo

Since Specialization
Citations

This map shows the geographic impact of Qinguo Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinguo Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinguo Mo more than expected).

Fields of papers citing papers by Qinguo Mo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qinguo Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinguo Mo. The network helps show where Qinguo Mo may publish in the future.

Co-authorship network of co-authors of Qinguo Mo

This figure shows the co-authorship network connecting the top 25 collaborators of Qinguo Mo. A scholar is included among the top collaborators of Qinguo Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qinguo Mo. Qinguo Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Yan, Qingyuan Zhang, Liqiu Liao, et al.. (2025). SHR-A1811 plus adebrelimab in unresectable or metastatic triple-negative breast cancer: Results from a phase 1b/2 expansion cohort.. Journal of Clinical Oncology. 43(16_suppl). 1103–1103. 1 indexed citations
2.
3.
4.
Tan, Qixing, et al.. (2022). Predictive and prognostic effect of HO-1 expression in breast cancer patients undergoing neoadjuvant chemotherapy. Breast Cancer Research and Treatment. 193(2). 393–403. 7 indexed citations
5.
Qin, Qinghong, et al.. (2021). Significance of Oncotype DX 21-Gene Test and Expression of Long Non-Coding RNA MALAT1 in Early and Estrogen Receptor-Positive Breast Cancer Patients. Cancer Management and Research. Volume 13. 587–593. 13 indexed citations
6.
Tan, Qixing, et al.. (2021). Impact of Primary Site Surgery on Survival of Patients with de novo Stage IV Breast Cancer. Cancer Management and Research. Volume 13. 319–327. 8 indexed citations
7.
Huang, Zhen, et al.. (2019). ALOX12 inhibition sensitizes breast cancer to chemotherapy via AMPK activation and inhibition of lipid synthesis. Biochemical and Biophysical Research Communications. 514(1). 24–30. 30 indexed citations
8.
Qin, Qinghong, et al.. (2018). SIRT1 promotes proliferation, migration, and invasion of breast cancer cell line MCF-7 by upregulating DNA polymerase delta1 (POLD1). Biochemical and Biophysical Research Communications. 502(3). 351–357. 42 indexed citations
9.
Zhou, Xiao‐Hua, Zhen Huang, Huawei Yang, et al.. (2017). β-Glucosidase inhibition sensitizes breast cancer to chemotherapy. Biomedicine & Pharmacotherapy. 91. 504–509. 24 indexed citations
10.
Wei, Changyuan, et al.. (2017). Efficacy of Iodine-125 Seed Implantation in Locoregionally Recurrent and Unresectable Breast Cancer: a Retrospective Study. Pathology & Oncology Research. 25(1). 327–332. 8 indexed citations
11.
Zhu, Xiao Dong, et al.. (2017). Prediction of neoadjuvant chemotherapy response using diffuse optical spectroscopy in breast cancer. Clinical & Translational Oncology. 20(4). 524–533. 8 indexed citations
12.
Zhu, Xiao Dong, Ying Cui, Qinguo Mo, et al.. (2017). Development of video-assisted breast cancer surgery: Initial experience with a novel method for creating working space without prior liposuction. Molecular and Clinical Oncology. 7(1). 32–38. 19 indexed citations
13.
Tan, Qixing, Qinghong Qin, Weiping Yang, et al.. (2016). Combination of 125I brachytherapy and chemotherapy for unresectable recurrent breast cancer. Medicine. 95(44). e5302–e5302. 4 indexed citations
14.
Wei, Changyuan, Qixing Tan, Xiao Dong Zhu, et al.. (2015). Expression of CDKN1A/p21 and TGFBR2 in breast cancer and their prognostic significance.. PubMed. 8(11). 14619–29. 50 indexed citations
15.
Huang, Jinbo, et al.. (2015). Harmonic Scalpel versus Electrocautery Dissection in Modified Radical Mastectomy for Breast Cancer: A Meta-Analysis. PLoS ONE. 10(11). e0142271–e0142271. 39 indexed citations
16.
Tan, Qixing, Qinghong Qin, Weiping Yang, Qinguo Mo, & Changyuan Wei. (2014). Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy.. PubMed. 7(10). 6862–70. 47 indexed citations
17.
Zhong, Jian‐Hong, Bang‐De Xiang, Wen‐Feng Gong, et al.. (2013). Comparison of Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma after Liver Resection or Transarterial Chemoembolization. PLoS ONE. 8(7). e68193–e68193. 123 indexed citations
18.
Zhong, Jian‐Hong, Xue‐Mei You, Wen‐Feng Gong, et al.. (2012). Epidermal Growth Factor Gene Polymorphism and Risk of Hepatocellular Carcinoma: A Meta-Analysis. PLoS ONE. 7(3). e32159–e32159. 45 indexed citations
19.
Liang, Anmin, et al.. (2004). [Comprehensive therapy for primary liver cancer: a report of 607 cases].. PubMed. 23(2). 211–4. 2 indexed citations
20.
Mo, Qinguo, et al.. (2003). [Surgery-predominant comprehensive therapy for 134 patients with small hepatocellular carcinoma].. PubMed. 22(2). 189–91. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miral S. Grandhi Breakdown of academic impact, for papers by Yifu He Breakdown of academic impact, for papers by Marina Ichetovkin Breakdown of academic impact, for papers by Norio Noguchi Breakdown of academic impact, for papers by Hongchuan Zhao Breakdown of academic impact, for papers by Tianyi Chi Breakdown of academic impact, for papers by Nguyen H. Tran Breakdown of academic impact, for papers by Tsai‐Sheng Yang Breakdown of academic impact, for papers by Yu Wen
Rankless by CCL
2026